Supplementary Data S6 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

Supplementary Data S6 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

<p>Supplementary Data 6 describes the patients included in the RNA sequencing analysis as well as AR and NEPC scores.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Naoual Menssouri (16617248) (author)
Diğer Yazarlar:	Loïc Poiraudeau (16617251) (author), Carole Helissey (15122919) (author), Ludovic Bigot (16617254) (author), Jonathan Sabio (16617257) (author), Tony Ibrahim (16617260) (author), Cédric Pobel (16617263) (author), Claudio Nicotra (16617266) (author), Maud Ngo-Camus (16617269) (author), Ludovic Lacroix (15030059) (author), Etienne Rouleau (15009254) (author), Lambros Tselikas (15019536) (author), Anne Chauchereau (15022332) (author), Félix Blanc-Durand (15049400) (author), Alice Bernard-Tessier (16617272) (author), Anna Patrikidou (16617275) (author), Natacha Naoun (16617278) (author), Ronan Flippot (16426556) (author), Emeline Colomba (16617281) (author), Alina Fuerea (16617284) (author), Laurence Albiges (15047814) (author), Pernelle Lavaud (15119297) (author), Paul van de Wiel (16617287) (author), Eveline den Biezen (16617290) (author), Yvonne Wesseling-Rozendaal (16617293) (author), Santiago Ponce (16617296) (author), Stefan Michiels (9081965) (author), Christophe Massard (14952598) (author), Daniel Gautheret (10927940) (author), Fabrice Barlesi (15045504) (author), Fabrice André (15038378) (author), Benjamin Besse (15061674) (author), Jean-Yves Scoazec (15036392) (author), Luc Friboulet (15025943) (author), Karim Fizazi (15093615) (author), Yohann Loriot (15123021) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Therapeutic Research and Development Drug Resistance Genitourinary Cancers Prostate cancer Translational Research
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Data S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S10 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S11 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S12 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S13 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S14 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S3 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S5 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S7 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S8 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S9 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Yazar:: Zachary Quinn (15052893)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Yazar:: Aurelius Omlin (14971513)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Yazar:: Aurelius Omlin (14971513)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Sofie H. Tolmeijer (15313251)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Sofie H. Tolmeijer (15313251)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Sofie H. Tolmeijer (15313251)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
Yazar:: Michael D. Nyquist (16918265)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
Yazar:: Michael D. Nyquist (16918265)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Yazar:: Charles Blatti (15292859)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 3 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Yazar:: Charles Blatti (15292859)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Yazar:: Charles Blatti (15292859)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_etdhb019vt0oaq7a3qv9qc7889